CSIMarket
 


Biorestorative Therapies Inc   (BRTX)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

BRTX's Net Cash Flow Growth by Quarter and Year

Biorestorative Therapies Inc 's Net Cash Flow results by quarter and year




BRTX Net Cash Flow (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -4.90 19.27 -0.12
III Quarter September - -11.36 -0.74 0.29
II Quarter June -0.05 -1.39 -0.56 0.00
I Quarter March 0.16 -1.70 2.89 -0.12
FY   0.11 -19.35 20.86 0.05



BRTX Net Cash Flow second quarter 2023 Y/Y Growth Comment
Biorestorative Therapies Inc in the second quarter 2023 recorded net cash outflow of $ -0.05 millions.

According to the results reported in the second quarter 2023, Biorestorative Therapies Inc achieved the best Net Cash Flow growth in Healthcare Facilities industry. While Biorestorative Therapies Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the second quarter 2023.




BRTX Net Cash Flow ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - 41620 % -85.71 %

Financial Statements
Biorestorative Therapies Inc 's second quarter 2023 Net Cash Flow $ -0.05 millions BRTX's Income Statement
Biorestorative Therapies Inc 's second quarter 2022 Net Cash Flow $ -1.39 millions Quarterly BRTX's Income Statement
New: More BRTX's historic Net Cash Flow Growth >>


BRTX Net Cash Flow (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - 41620 % -85.71 %




Net Cash Flow second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biorestorative Therapies Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BRTX's II. Quarter Q/Q Net Cash Flow Comment
Recent accomplishment of -0.05 millions by Biorestorative Therapies Inc look even less good compare to the 0.16 millions net cash outflow in the first quarter.

Within Healthcare Facilities industry Biorestorative Therapies Inc achieved highest sequential Net Cash Flow growth. While Biorestorative Therapies Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BRTX's II. Quarter Q/Q Net Cash Flow Comment
II. Quarter 2023 net cash outflow of -0.05 millions by Biorestorative Therapies Inc appear even more unfavourable considering the net cash outflow 0.16 millions in the first quarter.

Within Healthcare Facilities industry Biorestorative Therapies Inc achieved highest sequential Net Cash Flow growth. While Biorestorative Therapies Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Biorestorative Therapies Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Net Cash Flow 12 Months Ending $ -16.15 $ -17.49 $ -19.35 $ 4.81 $ 15.43
Y / Y Net Cash Flow Growth (TTM) - - - 229.51 % 518.27 %
Year on Year Net Cash Flow Growth Overall Ranking # 92 # 141 # 0 # 180 # 128
Seqeuential Net Cash Flow Change (TTM) - - - -68.81 % -5.08 %
Seq. Net Cash Flow Growth (TTM) Overall Ranking # 364 # 411 # 0 # 838 # 548




Cumulative Net Cash Flow growth Comment
Biorestorative Therapies Inc realized trailing twelve months net cash outflow of $ -16 millions, in the Jun 30 2023, compare to Net Cash Flow of $ 15 millions a year ago.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 92, from total ranking in previous quarter at 141.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
35559.96 %
2737.31 %
-280.23 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 15
Overall # 92

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
35559.96 %
2737.31 %
-280.23 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 64
S&P 500 # 364
Cumulative Net Cash Flow growth Comment
Biorestorative Therapies Inc realized trailing twelve months net cash outflow of $ -16 millions, in the Jun 30 2023, compare to Net Cash Flow of $ 15 millions a year ago.

Among companies within the Healthcare sector 14 other companies have achieved higher trailing twelve month Net Cash Flow growth. While Total ranking has impoved so far to 92, from total ranking in previous quarter at 141.

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
35559.96 %
2737.31 %
-280.23 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry # 4
Healthcare Sector # 15
Overall # 92

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
35559.96 %
2737.31 %
-280.23 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry # 4
Sector # 64
S&P 500 # 364




Other Net Cash Flow Growth
Healthcare Facilities Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
BRTX's Net Cash Flow Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for BRTX's Competitors
Net Cash Flow Growth for Biorestorative Therapies Inc 's Suppliers
Net Cash Flow Growth for BRTX's Customers

You may also want to know
BRTX's Annual Growth Rates BRTX's Profitability Ratios BRTX's Asset Turnover Ratio BRTX's Dividend Growth
BRTX's Roe BRTX's Valuation Ratios BRTX's Financial Strength Ratios BRTX's Dividend Payout Ratio
BRTX's Roa BRTX's Inventory Turnover Ratio BRTX's Growth Rates BRTX's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Jun 30 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Jun 30 2023
Spruce Biosciences Inc -1.28%$ -1.282 millions
Progyny Inc -4.14%$ -4.142 millions
Stereotaxis Inc -6.01%$ -6.013 millions
Catalyst Pharmaceuticals Inc -6.15%$ -6.146 millions
Cardiff Lexington Corporation-13.04%$ -13.036 millions
Lifevantage Corp-13.28%$ -13.283 millions
Abbvie inc -15.48%$ -15.477 millions
Avita Medical Inc -15.78%$ -15.781 millions
Tenon Medical Inc -16.42%$ -16.417 millions
Sensus Healthcare Inc -18.33%$ -18.328 millions
Cyteir Therapeutics Inc -19.66%$ -19.660 millions
Qrons Inc -20.11%$ -20.111 millions
Cutera Inc -20.16%$ -20.164 millions
Collegium Pharmaceutical Inc -20.31%$ -20.313 millions
Harrow Inc -21.92%$ -21.915 millions
Vertex Pharmaceuticals Inc-22.03%$ -22.025 millions
Dynavax Technologies Corporation-24.67%$ -24.671 millions
Arcellx Inc -27.49%$ -27.491 millions
Applied Therapeutics inc -27.49%$ -27.492 millions
Standard Biotools Inc -35.46%$ -35.461 millions
Royalty Pharma Plc-37.64%$ -37.638 millions
Horizon Therapeutics Public Limited Company-38.80%$ -38.803 millions
Cohbar Inc -39.13%$ -39.128 millions
Fonar Corporation-39.55%$ -39.551 millions
Tenaya Therapeutics Inc -39.60%$ -39.603 millions
Endra Life Sciences Inc -40.63%$ -40.631 millions
Tarsus Pharmaceuticals Inc -42.04%$ -42.041 millions
Cassava Sciences Inc-42.94%$ -42.941 millions
Lemaitre Vascular Inc -46.23%$ -46.232 millions
Omeros Corp-46.38%$ -46.375 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com